Kamada (KMDA) EBT Margin Growth (3y) (2015 - 2026)
Kamada (KMDA) EBT Margin Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 1,282.00 |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | -491.00 |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 58.00 |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | -861.00 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -1,020.00 |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | -995.00 |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 1,157.00 |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Kamada | 464.34 Mn | 434.87 Mn | 22.47 Mn | 1,346.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,393.00 |
| Mar 31, 2026 | 1,192.00 |
| Dec 31, 2025 | 345.00 |
| Sep 30, 2025 | 1,354.00 |
| Jun 30, 2025 | -1,677.00 |
| Mar 31, 2025 | 837.00 |
| Dec 31, 2024 | 2,162.00 |
| Sep 30, 2024 | 569.00 |
| Jun 30, 2024 | -398.00 |
| Mar 31, 2024 | -433.00 |
| Dec 31, 2023 | 773.00 |
| Sep 30, 2023 | -1,165.00 |
| Jun 30, 2023 | -654.00 |
| Mar 31, 2023 | -1,689.00 |
| Dec 31, 2022 | -1,006.00 |
| Sep 30, 2022 | -1,826.00 |
| Jun 30, 2022 | -131.00 |
| Mar 31, 2022 | -1,220.00 |
| Dec 31, 2021 | -4,809.00 |
| Sep 30, 2021 | -1,146.00 |